Senores Pharmaceuticals Reports Q2FY27 IPO Proceeds Utilization and Object Revisions
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 10:48 pm
Senores Pharmaceuticals Reports Q2FY27 IPO Proceeds Utilization and Object Revisions CARE Ratings' monitoring report for Senores Pharmaceuticals reveals cumulative utilization of Rs. 418.83 crore from its Rs. 500.00 crore fresh IPO proceeds through 30th Sep'26, with Rs. 19.37 crore deployed during Q2FY27. Net unutilized proceeds of Rs. 81.17 crore remain parked primarily in bank fixed deposits. Shareholders approved revisions to issue objects via postal ballot on 4th Aug'26, reallocating funds toward subsidiary ANDA acquisitions (Rs. 15.39 crore) and plant expansions in Vadodara (Rs. 25.00 crore) and Atlanta (Rs. 24.63 crore).
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding media release 路 29 Oct 2026
